Amneal Pharmaceuticals, Inc. (AMRX) revenue & profit
Amneal Pharmaceuticals, Inc. (AMRX): revenue $3B, net income $72.1M in 2025; latest quarter +9.9% year over year. From SEC filings.
$3BRevenue 2025
TickerAMRX (Nasdaq)
IndustryOther
Revenue 2025$3B
Net income 2025$72.1M
Net margin2.4%
Annual revenue growth+8%
Latest quarter (2026 Q2) · Revenue$796.2M
vs. same quarter last year+9.9%
Latest quarter · Net income$57.7M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $2.2B | -$270.6M | |
| 2023 | $2.4B | -$84M | |
| 2024 | $2.8B | -$116.9M | |
| 2025 | $3B | $72.1M |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.